Technical Analysis for BLU - BELLUS Health Inc.

Grade Last Price % Change Price Change
grade B 8.6 -0.35% -0.030
BLU closed down 0.35 percent on Friday, October 11, 2019, on 29 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical BLU trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction -0.35%
20 DMA Resistance Bearish 3.86%
Down 3 Days in a Row Weakness 3.86%
Down 4 Days in a Row Weakness 3.86%
Down 3 Days in a Row Weakness 0.12%
Fell Below 20 DMA Bearish -5.39%
20 DMA Support Bullish -7.13%
Doji - Bearish? Reversal -7.13%
Crossed Above 20 DMA Bullish -7.53%
Up 3 Days in a Row Strength -7.53%

Older signals for BLU ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
BELLUS Health Inc. is a drug development company focused on rare diseases. The business activities of the Company are development of the Company's core technology platform, amyloid inhibitors, which focus on chemical compounds that could have the potential to inhibit the formation, deposition and toxicity of amyloid fibrils, which are the underlying causes of certain diseases. The Company operates in the business segment of development of drugs for health solutions. It is focused on developing drugs for rare diseases, starting with conditions that affect the kidneys. Its pipeline of rare disease projects includes KIACTA in Phase III for Amyloid A (AA) amyloidosis; KIACTA for sarcoidosis; clinical stage Shigamab for Hemolytic Uremic Syndrome caused by Shiga toxin-producing E. coli (sHUS), and a research-stage project for amyloid light-chain (AL) amyloidosis. It is partnered with global private equity firm Auven Therapeutics for the development of KIACTA.
Medical Specialties RTT Biology Drug Development Chemical Compounds Amyloid Amyloidosis Rare Diseases
Is BLU a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.2
52 Week Low 0.66
Average Volume 119,314
200-Day Moving Average 3.2238
50-Day Moving Average 7.9208
20-Day Moving Average 8.937
10-Day Moving Average 8.759
Average True Range 0.5674
ADX 21.37
+DI 22.9287
-DI 21.5249
Chandelier Exit (Long, 3 ATRs ) 8.267800000000001
Chandelier Exit (Short, 3 ATRs ) 9.752200000000001
Upper Bollinger Band 9.9143
Lower Bollinger Band 7.9597
Percent B (%b) 0.33
BandWidth 21.870874
MACD Line 0.0942
MACD Signal Line 0.2397
MACD Histogram -0.1455
Fundamentals Value
Market Cap 575.03 Million
Num Shares 66.9 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 37.49
Price-to-Book 2.65
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.155
Resistance 3 (R3) 9.197 9.053 9.063
Resistance 2 (R2) 9.053 8.912 9.033 9.032
Resistance 1 (R1) 8.827 8.825 8.755 8.785 9.001
Pivot Point 8.683 8.683 8.648 8.663 8.683
Support 1 (S1) 8.457 8.542 8.385 8.415 8.199
Support 2 (S2) 8.313 8.455 8.293 8.168
Support 3 (S3) 8.087 8.313 8.138
Support 4 (S4) 8.045